Table 2. Overview of isolates and outcome of the stability experiment for the Belgian isolates(n = 22).
| ID Number | Phage Type | Initial MLVA profile | Final MLVA profile | Frequence of the Phage type and MLVA profile (%/%) |
|---|---|---|---|---|
| SE1: 07–1456 | PT8 | 2–13–7–3–2 | 2–13–7–3–2 | 18.6/3.1 |
| SE2: 07–5973 | PT28 | 2–12–7–3–2 | 2–12–7–3–2 | 4.1/0.01 |
| SE3: 09–2821 | PT8 | 2–13–7–3–2 | 2–13–7–3–2 | 18.6/3.1 |
| SE4: 11–2950 | PT28 | 2–10–7–3–2 | 2–10–7–3–2 | 4.1/9.5 |
| SE5: 12–0215 | PT14b | 2–13–7–3–2 | 2–13–7–3–2 | 4.6/3.1 |
| SE6: 12–0266 | PT4 | 3–9–5–4–1 | 3–9–5–4–1 | 19/6.7 |
| SE7: 12–0429 | PT21 | 3–11–5–4–1 | 3–11–5–4–1 | 16.3/9.2 |
| SE8: 12–1442 | PT21 | 3–11–5–4–1 | 3–11–5–4–1 | 16.3/9.2 |
| SE9: 12–2353 | P13 | 2–12–7–3–2 | 2–12–7–3–2 | 3.4/0.01 |
| SE10: 12–2488 | PT21 | 3–9–5–4–1 | 3–9–5–4–1 | 16.3/6.7 |
| SE11: 12–2592 | PT14b | 3–10–5–4–1 | 3–10–5–4–1 | 4.6/26.8 |
| SE12: 12–2630 | PT21 | 3–10–5–4–1 | 3–10–5–4–1 | 16.3/26.8 |
| SE13: 12–3578 | PT1 | 3–10–5–4–1 | 3–10–5–4–1 | 11.7/26.8 |
| SE14: 12–3599 | PT4 | 3–11–5–4–1 | 3–11–5–4–1 | 19/9.2 |
| SE15: 12–3693 | PT4 | 3–10–5–4–1 | 3–10–5–4–1 | 19/26.8 |
| SE16: 12–3723 | PT8 | 2–10–7–3–2 | 2–10–7–3–2 | 18.6/9.5 |
| SE17: 12–4071 | PT8 | 2–11–7–2–2 | 2–11–7–2–2 | 18.6/3.4 |
| SE18: 12–4164 | PT8 | 2–11–7–2–2 | 2–11–7–2–2 | 18.6/3.4 |
| SE19: 12–4561 | PT8 | 2–11–7–3–2 | 2–11–7–3–2 | 18.6/3.4 |
| SE20: 12–4593 | PT4 | 3–10–5–3–1 | 3–10–5–3–1 | 19/2.4 |
| SE21: 12–4666 | PT6 | 3–10–5–3–1 | 3–10–5–3–1 | 8.5/2.4 |
| SE22: 12–4775 | PT4 | 3–11–5–3–1 | 3–11–5–3–1 | 19/3.6 |